Fortune News | Feb 29,2020
October 2 , 2021
By Abdourahmane Diallo ( is the CEO of the RBM Partnership to End Malaria. )
Consider the humble mosquito. When compared to some of the world’s most notorious and vicious predators, it might not look like much. And yet it has killed more people in history than any other creature. As a carrier for some of the world’s deadliest diseases, including malaria, yellow fever, Zika, dengue, and chikungunya, it instils fear in tens of millions of people around the world.
Malaria, the oldest of these diseases, dates back to the time of the dinosaurs and continues to have a devastating impact on people’s lives. Each day, it deprives thousands of young people of a future. Among the 400,000 deaths from malaria recorded in 2019, two-thirds were children under the age of five, and almost all lived in Africa.
Throughout my career in public health, I have seen modern technology transform our centuries-old fight against malaria in the space of just a few decades. Insecticide-treated mosquito nets, indoor residual spraying of homes, rapid diagnostic tests, and new treatments and prophylactics were not even part of the conversation when I started work on my medical degree. Now, these interventions are saving lives every day.
Ensuring wider access to these innovations has been instrumental to the progress we have made in ending suffering for millions of people and eliminating the disease in many countries. But it is clear that these tools will not be enough to achieve the ultimate goal of eradication.
Mosquitoes and the malaria parasite have survived as long as they have by constantly adapting to new conditions. Now, growing drug and insecticide resistance in the Greater Mekong Subregion and Sub-Saharan Africa threatens to weaken our current tools for prevention and treatment. Collaboration between scientists and the private sector is urgently needed to develop new medicines to combat resistance to artemisinin, the main component of the first-line drug that treats the most common form of the disease, and to insecticides that stop the malaria-carrying Anopheles mosquitoes in their tracks.
Some potentially game-changing innovations have emerged in recent years. With further development, these could (once again) transform the fight against malaria. For example, the Innovative Vector Control Consortium’s New Nets Project is currently piloting mosquito nets treated with novel insecticide combinations to combat resistance throughout Sub-Saharan Africa. The Medicines for Malaria Venture is bringing together leading pharmaceutical companies to speed up the drug development process. And researchers at Target Malaria are conducting trials of gene drives to reduce or eliminate Anopheles mosquitos’ malaria-carrying capacity at the species level.
While there is still a long way to go, it is worth noting that these advances would have been unimaginable not long ago. Moreover, the rapid development of vaccines against COVID-19 has strengthened the case for increased investment in innovation to tackle other deadly diseases.
The global malaria community has been hoping for an effective malaria vaccine for more than three decades. While the malaria parasite is considerably more complex than the coronavirus, there have been recent advances in preventive treatments. The World Health Organisation-backed RTS,S vaccine, manufactured by GSK, is already being piloted in three African countries and has recently been shown to reduce severe malaria cases and deaths among young children by 70pc when combined with seasonal malaria chemoprevention. This is a promising first-generation vaccine, but more investment is needed to create a highly effective, all-ages vaccine. And now, BioNTech has announced that it will pursue development of an mRNA vaccine against malaria, following the platform’s unprecedented success in developing vaccines against COVID-19.
While new technologies will help to accelerate progress, there is no silver bullet. Until we eradicate malaria, we will need constant innovation to stay one step ahead of evolution. These interventions must be deployed strategically in combination with existing malaria prevention and treatment measures.
We must also overcome long-standing barriers to scaling up innovations and making them universally accessible, even for hard-to-reach populations. New interventions will fall far short of their potential unless they are accompanied by steps to empower and support the health workers tasked with implementing them. Routine use of data to orchestrate more targeted deployments of treatments and preventive measures is crucial. The COVID-19 pandemic has offered a brutal reminder of how important it is to invest in real-time health information.
We have achieved a great deal thus far in our fight against malaria. But only by harnessing new discoveries and technologies, equipping countries with the right tools to meet their needs, and accelerating access to life-saving innovations can we consign malaria to the history books, alongside diseases like smallpox, and deliver a healthier, more prosperous world for all.
PUBLISHED ON Oct 02,2021 [ VOL 22 , NO 1118]
Fortune News | 41495 Views | Jul 18,2020
Fortune News | 35341 Views | Sep 01,2021
Photo Gallery | 27570 Views | May 06,2019
Photo Gallery | 25901 Views | Mar 17,2019
Commentaries | Oct 09,2021
Life Matters | Oct 09,2021
My Opinion | Oct 09,2021
Sunday with Eden | Oct 09,2021
Agenda | Oct 09,2021
Editorial | Oct 09,2021
August 28 , 2021 . By HAWI DADHI
The streets of Addis Abeba are as varied as they are many, although too many of them have yet to be named. From the narrow alleyways of the...
August 7 , 2021
There are a few without an opinion on Ethiopia’s federal structure, which is arranged along lingo-cultu...
July 24 , 2021
There was an alarming increase in the price of Teffin August 2017. It suddenly skyrocketed from 2,000 Br...
June 26 , 2021 . By HAWI DADHI and SAMUEL BOGALE
This past Monday was the second time Belay Zerihun, a second-time voter, has had to stand in a long queue...
Leaders of the National Election Board are in a charm offensive mood, of a sort. Last week, they organised a rare tour for members of the me...
When the country’s most senior diplomats and envoys return back to their posts after two-week debriefings, they leave behind a point or tw...
October 9 , 2021
Public offices have been having a field day in the past few years. From the Prime Min...
October 2 , 2021
Ethiopia`s Parliament will pick up a Prime Minister on Monday, October 4, 2021. The i...
September 26 , 2021
There are two editions of The Economist on Africa influenced by the narrative on the...
September 18 , 2021
It could be customary to wish well for the holiday seasons. If only the New Year cele...
PM Abiy Ahmed (PhD) at a Gala Dinner Called for the Awarding of the Félix Houphouët-Boigny Peace Prize
May 6 , 2019
Ethiopia is experiencing a nationwide social crisis unlike any other the young genera...
We have all heard it said, “looks can be deceiving,” which is often used to refer to something that seems good on the outside but does n...
October 9 , 2021
From Arat Kilo to Mesqel Square, October 4, 2021, was a busy day. At the former, Parliament opened its first business of the next five years...
October 9 , 2021 . By HAWI DADHI
The state monopoly over the logistics sector will end soon, with federal authorities allowing up to five...
Federal authorities gear up to amend compensation and premium rates for third-party motor insurance polic...
October 9 , 2021 . By BERSABEH GEBRE
The state-owned Ethiopian Shipping & Logistics Services Enterprise (ESLSE) is one step closer to acqu...
Or see contact page